Research News
View articles by month and year
-
Using Hormone Replacement Therapy for as Few as 3 Years Increases Risk
Using combination hormone replacement therapy for 3 years or more can increase the risk of lobular breast cancer.
-
Tamoxifen Plus Removing Ovaries Improves Survival for Premenopausal Women
Removing the ovaries and taking tamoxifen after breast cancer surgery had benefits for premenopausal women shows a new study done in Vietnam and China.
-
Simple Saliva Test May Detect Breast Cancer
Researchers are working to create a breast cancer screening test that uses saliva proteins to detect cancers.
-
Abnormal BRCA1 or BRCA2 Gene Increases Risk, Amount Varies Widely
A new study shows that the increase in risk associated with an abnormal BRCA1 or BRCA2 gene can vary widely among people who have an abnormal gene.
-
Chemotherapy After Surgery Reduces Recurrence Risk of Hormone-Receptor-Negative Breast Cancer
Chemotherapy after surgery significantly reduces the risk of hormone-receptor-negative breast cancer coming back and increases survival, according to a review of previous research.
-
Avastin Doesn’t Affect Overall Survival
Avastin combined with Taxol lengthens the time until advanced breast cancer progresses, but doesn't improve overall survival.
-
Hispanic Women More Likely to Have Abnormal BRCA1 Gene
A new analysis shows that Hispanic women and young African American women are more likely than white women to have abnormal BRCA1 genes.
-
Tamoxifen and Chemo Reduce Risk of New, Second Cancer
Tamoxifen and chemotherapy reduce the risk of developing a new, second breast cancer in the other breast.
-
Reconstruction After Breast Cancer Surgery Usually Not Discussed
Most surgeons don't talk about reconstruction with women diagnosed with breast cancer. But when reconstruction is discussed, it makes a big difference in which type of surgery is chosen.
-
Can Acupuncture Help Hot Flashes?
A new study still offers mixed results on whether acupuncture can help ease hot flashes.
